Fukumoto Seiji
Division of Nephrology & Endocrinology, Department of Medicine, University of Tokyo Hospital, Japan.
Endocr J. 2008 Mar;55(1):23-31. doi: 10.1507/endocrj.kr07e-002. Epub 2007 Sep 14.
Fibroblast growth factors (FGFs) are humoral factors with diverse biological functions. While most FGFs were shown to work as local factors regulating cell growth and differentiation, recent investigations indicated that FGF19 subfamily members, FGF15/19, FGF21 and FGF23 work as systemic factors. FGF15/19 produced by intestine inhibits bile acid synthesis and FGF21from liver is involved in carbohydrate and lipid metabolism. In addition, FGF23 was shown to be produced by bone and regulate phosphate and vitamin D metabolism. Furthermore, these FGFs require klotho or betaklotho for their actions in addition to canonical FGF receptors. It is possible that these FGFs together with their receptor systems might be targets for novel therapeutic measures in the future.
成纤维细胞生长因子(FGFs)是具有多种生物学功能的体液因子。虽然大多数FGFs被证明作为调节细胞生长和分化的局部因子发挥作用,但最近的研究表明,FGF19亚家族成员FGF15/19、FGF21和FGF23作为全身因子发挥作用。肠道产生的FGF15/19抑制胆汁酸合成,肝脏产生的FGF21参与碳水化合物和脂质代谢。此外,FGF23被证明由骨骼产生并调节磷酸盐和维生素D代谢。此外,除了典型的FGF受体外,这些FGFs还需要klotho或β-klotho才能发挥作用。这些FGFs及其受体系统有可能成为未来新型治疗措施的靶点。